Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2005
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/15/2005US6867178 Calorically dense nutritional composition
03/15/2005US6867176 Method for preparing zinc-oligopeptide easily absorbable by the human body
03/15/2005US6867003 Grb14, Grb14 fusion proteins, and screening methods
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/15/2005CA2382549C Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
03/15/2005CA2121678C Vitamin d amide derivatives
03/10/2005WO2005021572A1 Ptp1b antisense compound
03/10/2005WO2005021566A2 Glucopyranosyloxy- pirazoles, drugs containing said compounds the use and production method thereof
03/10/2005WO2005021555A1 Bicyclic piperazine compound and use thereof
03/10/2005WO2005021550A1 Bicyclic pyrazole derivative
03/10/2005WO2005021543A1 Phosphoric acid salt of 5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2, 4-thiazolidinedione
03/10/2005WO2005021541A2 Process for the production of polymorphs of rosiglitazone maleate
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021528A1 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/10/2005WO2005021525A1 Aryl piperidine amides
03/10/2005WO2005021495A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/10/2005WO2005021486A1 Ester derivative and medicinal use thereof
03/10/2005WO2005021039A1 Combination of cicletanine and an oral antidiabetic and/or blood lipid-lowering agent for treating diabetes and metabolic syndrome
03/10/2005WO2005021038A2 Agent for treating metabolic syndrome
03/10/2005WO2005021026A2 Methods for treating or ameliorating ghrelin-associated diseases and disorders
03/10/2005WO2005021015A1 Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia
03/10/2005WO2005021013A1 β-HYDROXY SHORT TO MEDIUM CHAIN FATTY ACID POLYMER
03/10/2005WO2005021012A1 Drug carrier having gemcitabine enclosed therein
03/10/2005WO2005020992A1 Novel medical use of selective cb1-receptor antagonists
03/10/2005WO2005020988A1 Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/10/2005WO2005020987A1 Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
03/10/2005WO2005020986A1 Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
03/10/2005WO2005020985A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
03/10/2005WO2005020983A2 Combination therapy for glycaemic control
03/10/2005WO2005020977A1 Alpha-ketoglutarate potentiators of insulin secretion
03/10/2005WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
03/10/2005WO2004087880A3 Compounds and their use to treat diabetes and related disorders
03/10/2005WO2004069236A9 Inhibitor for perioperative blood sugar elevation
03/10/2005WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005US20050054731 Includes a biguanide hypoglycemic agent, a lipid lowering agent, a blood pressure lowering agent and, preferably, an anti-platelet agent
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054713 3-Substituted oxindole beta3 agonists
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
03/10/2005US20050054696 Indole compounds and medicinal use thereof
03/10/2005US20050054685 Pharmaceutical composition
03/10/2005US20050054684 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050054635 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders
03/10/2005US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use
03/10/2005US20050054628 2-Substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054621 Fractionation of phytosterol esters in oil
03/10/2005US20050054605 Partial or full A1 agonists - N6 heterocyclic 5' thio substituted adenosine derivatives
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054593 New drug
03/10/2005US20050054584 Reducing weight and damage cuased by diabetes; antidiabetic agents
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054566 Calcium-influx inhibitory factor and method of isolation thereof
03/10/2005US20050054565 Agonists and antagonists of moxifin for the treatment of metabolic disorders
03/10/2005US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053661 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053588 Conversion of liver stem and progenitor cells to pancreatic functional cells
03/10/2005CA2539032A1 Glucopyranosyloxy-pirazoles, drugs containing said compounds the use and production method thereof
03/10/2005CA2537535A1 Novel medical use of selective cb1-receptor antagonists
03/10/2005CA2537180A1 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
03/10/2005CA2537090A1 Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/10/2005CA2536784A1 Process for the production of polymorphs of rosiglitazone maleate
03/10/2005CA2536461A1 Aryl piperidine amides
03/10/2005CA2536432A1 Combination therapy for glycaemic control
03/09/2005EP1512752A1 Method of diagnosis of obesity
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511811A2 Oil-soluble pigment compositions
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511757A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
03/09/2005EP1511756A2 Gangliosides with a modified acyl function
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511727A2 Aromatic sulfones and their medical use
03/09/2005EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS
03/09/2005EP1511723A1 Sulfone liver x-receptor modulators
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/09/2005EP1511717A1 Crystalline form of nateglinide
1 ... 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 ... 1298